4119 — SCI Pharmtech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual cashflow statement for SCI Pharmtech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	455	65.5	388	364	647
Depreciation
Amortisation
Non-Cash Items	577	5.36	-73.2	37.5	20.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-194	146	-109	-331	-40.8
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	972	280	297	216	861
Capital Expenditures	-218	-775	-1,168	-1,029	-947
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-211	235	158	163	-62.7
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-429	-540	-1,009	-866	-1,009
Financing Cash Flow Items	—	—	1	0	0.228
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-463	-41.5	547	1,426	-211
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	79.5	-301	-165	775	-360